First described in 1990 [5], primary hyperparathyroidism remains the most common manifestation of this syndrome, with most CDC73 mutation carriers developing hyperparathyroidism in late adolescence or early adulthood [4] and an estimated 75%–100% developing hyperparathyroidism by age 70 [2, 4]. This evidence concerns the gene CDC73 and primary hyperparathyroidism.